a-practical-novel-method-to-extract-genomic-dna-from-blood-collection

A Practical and Novel Method to Extract Genomic DNA from Blood Collection Kits for Plasma Protein Preservation

Laboratory tests can be done on the cellular or  fluid portions of the blood. The use of different blood collection tubes  determines the portion of the ...

Emory University School of Medicine and Children's Health Care of Atlanta

Lipid peroxidation and antioxidant status in the blood of children with aplastic anemia.

Lipides peroxydation antioxydant statut et dans le sang des enfants atteints d&#39;an&eacute;mie aplasique.

Lipido perossidazione e antiossidante status nel sangue dei bambini con anemia aplastica.

After implementing measures to control lead pollution in many countries, blood lead levels (BLLs) in children have been declined. The phase-out of leaded petrol began in Lucknow, the capital of most populated state, Uttar Pradesh in India on April 1, 2000. We evaluated the mean BLL and associated risk factors for lead exposure in Lucknow children (3-12 years) after petrol lead phase-out activity. The mean BLL of the 200 children was 9.3 microg/dL (range: 1.0-27.9 microg/dL). Seventy-four children (37%) had BLL above the Centre for Disease Control and Prevention's (CDC) level of concern (10 microg/dL). When these data were compared with BLLs determined by the George Foundation among the children of Mumbai, Bangalore, Kolkata, Chennai, Hyderabad, and Delhi during the year 1997 when leaded petrol was in use, where 62%, 62%, 87%, 96%, 43%, and 95%, respectively, then exceeded the CDC intervention level. Further, BLL of present study was very close to Mumbai children (age < or =12 years) estimated following the introduction of unleaded petrol, and 33% children had BLL above the CDC concern level with an average 8.4 microg/dL. Low socioeconomic status, proximity of home to traffic density, and mother's illiteracy were the factors associated with elevated BLLs in Lucknow children (P < 0.05). Overall, results indicate a declining trend of BLL in Lucknow children when compared with those reported from other cities of India when leaded petrol was in practice. A national population-based study is recommended to determine the prevalence of elevated BLLs after the phase-out of leaded-petrol. In addition, future studies on other sources of lead exposure in Lucknow are warranted for public health purposes.

Blood lead levels in children of Lucknow, India.

Apr&egrave;s la mise en &oelig;uvre de mesures visant &agrave; lutter contre la pollution de plomb dans de nombreux pays, plomb&eacute;mie (couches) chez les enfants ont &eacute;t&eacute; diminu&eacute;e. L&#39;&eacute;limination de l&#39;essence au plomb a commenc&eacute; &agrave; Lucknow, la capitale de l&#39;&eacute;tat le plus peupl&eacute;, l&#39;Uttar Pradesh en Inde le 1er avril 2000. Nous avons &eacute;valu&eacute; la moyenne BLL et des facteurs de risque associ&eacute;s &agrave; l&#39;exposition plomb chez les enfants (3-12 ans) apr&egrave;s l&#39;essence plomb activit&eacute; d&#39;&eacute;limination progressive de la Lucknow. La BLL moyenne des 200 enfants &eacute;tait de 9,3 microg/dL (gamme : 1.0-27,9 microgrammes/dL). Soixante-quatre enfants (37 %) avaient BLL au-dessus du Centre for Disease Control and Prevention (CDC) niveau de pr&eacute;occupation (10 microg/dL). Lorsque ces donn&eacute;es ont &eacute;t&eacute; compar&eacute;es avec couches d&eacute;termin&eacute;es par le George Foundation parmi les enfants de Mumbai, Bangalore, Calcutta, Chennai, Hyderabad et Delhi au cours de l&#39;ann&eacute;e 1997, quand l&#39;essence au plomb &eacute;tait utilis&eacute;, o&ugrave; 62 %, 62 %, 87 %, 96 %, 43 % et 95 %, respectivement, puis d&eacute;passaient l&#39;intervention de la CDC niveau. En outre, BLL de la pr&eacute;sente &eacute;tude a &eacute;t&eacute; tr&egrave;s pr&egrave;s de Mumbai enfants (&acirc;ge &lt; ou = 12 ans) a estim&eacute; apr&egrave;s l&#39;introduction de l&#39;essence sans plomb, et 33 % des enfants avaient BLL au-dessus du niveau de pr&eacute;occupation du CDC avec une moyenne de 8,4 microgrammes/dL. Faible statut socio-&eacute;conomique, proximit&eacute; de la maison &agrave; la densit&eacute; du trafic et l&#39;analphab&eacute;tisme de la m&egrave;re ont &eacute;t&eacute; les facteurs associ&eacute;s &agrave; des couches &eacute;lev&eacute;es chez les enfants de Lucknow (P 0,05 &lt;). Globalement, les r&eacute;sultats indiquent une tendance &agrave; la baisse de BLL chez les enfants de Lucknow en comparaison avec celles des autres villes de l&#39;Inde lorsque l&#39;essence au plomb a &eacute;t&eacute; dans la pratique. Une &eacute;tude nationale sur la population est recommand&eacute;e pour d&eacute;terminer la pr&eacute;valence des couches &eacute;lev&eacute;es apr&egrave;s l&#39;&eacute;limination progressive de l&#39;essence au plomb. En outre, des &eacute;tudes ult&eacute;rieures sur d&#39;autres sources d&#39;exposition au plomb &agrave; Lucknow sont garantis &agrave; des fins de sant&eacute; publique.

Blood lead levels in children de Lucknow, en Inde.

Dopo l&#39;attuazione di misure per il controllo dell&#39;inquinamento di piombo in molti paesi, livelli di piombo nel sangue (inserimenti) nei bambini sono stati diminuiti. L&#39;eliminazione della benzina contenente piombo cominci&ograve; a Lucknow, la capitale dello stato pi&ugrave; popolato, Uttar Pradesh, in India su 1&deg; aprile 2000. Abbiamo valutato la media BLL e fattori di rischio associati per portare l&#39;esposizione nei bambini (3-12 anni) dopo benzina conducono attivit&agrave; di eliminazione di Lucknow. La media BLL dei 200 bambini era 9,3 microg/dL (range: 1.0-27,9 microg/dL). Settantaquattro bambini (37%) erano BLL sopra il centro for Disease Control and Prevention (CDC) livello di preoccupazione (10 microg/dL). Quando questi dati sono stati confrontati con inserimenti determinati da George Foundation tra i bambini di Mumbai, Bangalore, Kolkata, Chennai, Hyderabad e Delhi durante l&#39;anno 1997 quando benzina contenente piombo era in uso, dove il 62%, 62%, 87%, 96%, 43% e 95%, rispettivamente, quindi superato l&#39;intervento di CDC livello. Ulteriormente, BLL del presente studio &egrave; stato molto vicino a Mumbai bambini (et&agrave; &lt; o = 12 anni) stimato a seguito dell&#39;introduzione della benzina senza piombo, e il 33% dei bambini era BLL sopra il livello di preoccupazione di CDC con una media di 8,4 microg/dL. Basso status socio-economico, prossimit&agrave; della casa per densit&agrave; di traffico e l&#39;analfabetismo della madre sono stati i fattori associati con inserimenti elevati nei bambini di Lucknow (P &lt; 0,05). Nel complesso, i risultati indicano una tendenza al ribasso di BLL in bambini di Lucknow quando confrontati con quelli riportati da altre citt&agrave; dell&#39;India, quando la benzina al piombo &egrave; stato in pratica. Uno studio population-based nazionale raccomanda di determinare la prevalenza di inserimenti elevati dopo l&#39;eliminazione della benzina con piombo. Inoltre, gli studi futuri su altre fonti di esposizione al piombo in Lucknow sono garantiti per fini di sanit&agrave; pubblica.

Sangue portano livelli nei bambini di Lucknow, India.

Leukaemia and lymphoma are common paediatric haematological malignancies acquiring human parvovirus B19 (B19) infection. In some studies anaemia has been found in children with acute lymphoblastic leukaemia (ALL) during maintenance therapy and rarely in lymphoma. We studied frequency of B19 infection and its implications in new onset acute leukaemia (mostly ALL) and lymphoma in children.

A pilot study on parvovirus B19 infection in paediatric haematological malignancies.

La leuc&eacute;mie et lymphome sont communs p&eacute;diatrique h&eacute;mopathies malignes acquisition parvovirus humain B19 (B19) infection. Dans certaines &eacute;tudes, l&#39;an&eacute;mie a &eacute;t&eacute; trouv&eacute; chez les enfants atteints de leuc&eacute;mie lymphoblastique aigu&euml; (tous) au cours du traitement d&#39;entretien et rarement des lymphomes. Nous avons &eacute;tudi&eacute; la fr&eacute;quence des maladies infectieuses B19 et ses implications dans la leuc&eacute;mie aigu&euml; de la nouvelle apparition (pour la plupart tous) et lymphome chez les enfants.

Une &eacute;tude pilote sur l&#39;infection parvovirus B19 dans les h&eacute;mopathies malignes p&eacute;diatriques.

Leucemia e linfoma sono comuni neoplasie ematologiche pediatriche acquisizione umana parvovirus B19 (B19) infezione. In alcuni studi l&#39;anemia &egrave; stato trovato in bambini con leucemia linfoblastica acuta (ALL) durante la terapia di mantenimento e raramente nel linfoma. Abbiamo studiato la frequenza di infezione B19 e sue implicazioni nella leucemia acuta di nuova insorgenza (soprattutto tutte) e linfomi nei bambini.

Uno studio pilota sul parvovirus B19 infezione nelle neoplasie ematologiche pediatriche.

Esthesioneuroblastoma (ENB) is a rare, malignant neoplasm arising from the olfactory epithelial cells, with only approximately 100 pediatric cases being reported in the literature since its original description in 1924. As a result of its origin high in the nasal cavity, most patients have non-specific symptoms, precluding early diagnosis and leading to the development of locally advanced disease that usually has been found to involve the orbital cavity, paranasal sinuses, and anterior cranial fossa in children. The purpose of this paper was to report a rare case of pediatric esthesioneuroblastoma diagnosed following the patient's dental complaints, wherein local invasion of the tumor into the maxillofacial region was noticed before its extension into other vital structures.

Oral & maxillofacial manifestations in pediatric esthesioneuroblastoma-report of a case and review of literature.

Olfactif (ENB) est une tumeur rare, maligne r&eacute;sultant de cellules &eacute;pith&eacute;liales olfactives, avec seulement environ 100 cas p&eacute;diatriques &eacute;tant rapport&eacute;s dans la litt&eacute;rature depuis sa description originale en 1924. En raison de son origine &eacute;lev&eacute; dans les fosses nasales, la plupart des patients ont des sympt&ocirc;mes non sp&eacute;cifiques, excluant un diagnostic pr&eacute;coce et menant &agrave; l&#39;apparition d&#39;une maladie localement avanc&eacute;e qui a g&eacute;n&eacute;ralement &eacute;t&eacute; jug&eacute;e impliquent la cavit&eacute; orbitaire, des fosses nasales et la Fosse cr&acirc;nienne ant&eacute;rieure chez l&#39;enfant. Le but de cet article &eacute;tait de signaler un cas rare d&#39;olfactif p&eacute;diatrique diagnostiqu&eacute; suite &agrave; des plaintes dentaire du patient, dans lequel une invasion locale de la tumeur dans la r&eacute;gion maxillo-faciale a &eacute;t&eacute; remarqu&eacute;e avant son extension dans d&#39;autres structures vitales.

Manifestations orales &amp; maxillo-faciale p&eacute;diatrique olfactif-rapport d&#39;un cas et revue de la litt&eacute;rature.

Esthesioneuroblastoma (ENB) &egrave; una neoplasia maligna, rara, derivante dalle cellule epiteliali olfattive, con solo circa 100 casi pediatrici essendo riportati in letteratura dal suo originale descrizione nel 1924. A causa della sua origine alto nella cavit&agrave; nasale, la maggior parte dei pazienti hanno sintomi non specifici, precludendo la diagnosi precoce e che conduce allo sviluppo di malattia localmente avanzata che solitamente &egrave; stato trovato a coinvolgere la cavit&agrave; orbitale, seni paranasali e fossa cranica anteriore nei bambini. Lo scopo di questo libro &egrave; stato per segnalare un caso raro di Estesioneuroblastoma pediatrica diagnosticata dopo reclami dentale del paziente, in cui invasione locale del tumore nella regione maxillo-facciale &egrave; stato notato prima la sua estensione in altre strutture vitali.

Manifestazioni orali &amp; maxillo-facciale pediatrica Estesioneuroblastoma-report di un caso e revisione della letteratura.

Maladie de Crohn (MC) est hautement h&eacute;ritable. NOD2 a &eacute;merg&eacute; comme le g&egrave;ne de susceptibilit&eacute; principal chez les personnes d&#39;ascendance europ&eacute;enne ; Cependant, NOD2 ne semble pas contribuer &agrave; la susceptibilit&eacute; de CD parmi de nombreuses populations extra-europ&eacute;ennes. La population afro-am&eacute;ricaine (AA) d&#39;aujourd&#39;hui repr&eacute;sente un m&eacute;lange d&#39;Afrique de l&#39;Ouest (80 %) et l&#39;ascendance (20 %). &Eacute;tant donn&eacute; que les outils bas&eacute;s sur le g&eacute;notype deviennent de plus en plus disponibles pour CD, il est important que nous validons les variantes de risque dans des populations diff&eacute;rentes, tels que l&#39;AAs inusit&eacute;s.

Variantes de risque NOD2 communes dans les Afro-am&eacute;ricains avec la maladie de Crohn sont dues exclusivement au m&eacute;lange de race blanche r&eacute;cente.

La malattia di Crohn (CD) &egrave; altamente ereditabile. NOD2 &egrave; emerso come il gene di suscettibilit&agrave; principale tra gli individui dell&#39;ascendenza europea; Tuttavia, non sembra che NOD2 contribuiscono alla suscettibilit&agrave; CD tra molte popolazioni non europee. Popolazione afro-americana (AA) odierna rappresenta una mescolanza di Africa occidentale (80%) ed europeo (20%) ascendenza. Poich&eacute; gli strumenti basati sul genotipo stanno diventando sempre pi&ugrave; disponibili per CD, &egrave; importante che noi convalidare le varianti di rischio in popolazioni diverse, quali admixed AAs.

Comuni varianti di rischio NOD2 in afro-americani con la malattia di Crohn sono dovuti esclusivamente alla recente commistione caucasica.

Crohn's disease (CD) is highly heritable. NOD2 has emerged as the main susceptibility gene among individuals of European ancestry; however, NOD2 does not appear to contribute to CD susceptibility among many non-European populations. Today's African American (AA) population represents an admixture of West African (80%) and European (20%) ancestry. Since genotype-based tools are becoming increasingly available for CD, it is important that we validate the risk variants in different populations, such as admixed AAs.

Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture.

Recent advancements in the field of cancer diagnosis and chemotherapy have led to higher rates of survival for children with malignant tumors. More than 75% of pediatric patients diagnosed with malignancies survive more than 5 years. These advancements have resulted in additional responsibilities for dental professionals to diagnose, evaluate, prevent, stabilize, and manage the oral and dental problems that can compromise the quality of life of these children. This case report highlights the importance of professional and self-administered oral prophylactic measures and patient compliance in the successful oral rehabilitation of a pediatric patient with Burkitt lymphoma.

Dental management of a pediatric patient with Burkitt lymphoma: a case report.

Des avanc&eacute;es r&eacute;centes dans le domaine du diagnostic de cancer et la chimioth&eacute;rapie ont conduit &agrave; des taux plus &eacute;lev&eacute;s de la survie des enfants atteints de tumeurs malignes. Plus de 75 % des patients p&eacute;diatriques atteints de tumeurs malignes survivent plus de 5 ans. Ces progr&egrave;s ont donn&eacute; lieu &agrave; des responsabilit&eacute;s suppl&eacute;mentaires pour les professionnels dentaires diagnostiquer, &eacute;valuer, pr&eacute;venir, stabiliser et g&eacute;rer les probl&egrave;mes bucco-dentaires pouvant compromettre la qualit&eacute; de vie de ces enfants. Ce rapport de cas met en lumi&egrave;re l&#39;importance des mesures de prophylaxie orale professionnelles et auto-administr&eacute; et observance dans la r&eacute;habilitation orale r&eacute;ussie d&#39;un patient p&eacute;diatrique avec le lymphome de Burkitt.

Traitement dentaire d&#39;un patient p&eacute;diatrique avec le lymphome de Burkitt: a case report.

Recenti progressi nel campo della diagnosi di cancro e la chemioterapia hanno portato a pi&ugrave; alti tassi di sopravvivenza per i bambini con i tumori maligni. Oltre il 75% dei pazienti pediatrici diagnosticati con tumori maligni sopravvivere pi&ugrave; di 5 anni. Queste innovazioni hanno portato a ulteriori responsabilit&agrave; per professionisti dentali per diagnosticare, valutare, prevenire, stabilizzare e gestire i problemi dentali e orali che possono compromettere la qualit&agrave; della vita di questi bambini. Questo rapporto di caso evidenzia l&#39;importanza di misure di profilassi orale professionale e autogestite e compliance del paziente nella riabilitazione orale successo di un paziente pediatrico con linfoma di Burkitt.

Gestione dentale di un paziente pediatrico con linfoma di Burkitt: un rapporto di caso.

Alloanti-Kp(b) is a rare, clinically significant antibody against high frequency red cell antigen Kp(b) of Kell blood group system. We report here a case of Haemolytic disease of newborn (HDN) due to anti-Kp(b), which manifested as severe anaemia at the age of 1 month.

Late onset neonatal anaemia due to maternal anti-Kp(b) induced haemolytic disease of the newborn.

Alloanti-Kp(b) est un rare anticorps cliniquement significatif contre haute fr&eacute;quence h&eacute;maties syst&egrave;me de groupe sanguin de l&#39;antig&egrave;ne Kp(b) de Kell. Nous rapportons ici un cas de maladie h&eacute;molytique du nouveau-n&eacute; (HDN) en raison de la anti-Kp(b), qui se manifeste par une an&eacute;mie s&eacute;v&egrave;re &agrave; l&#39;&acirc;ge de 1 mois.

L&#39;an&eacute;mie n&eacute;onatale apparition tardive en raison de anti-Kp(b) maternelle induit une maladie h&eacute;molytique du nouveau-n&eacute;.

Alloanti-Kp(b) &egrave; un raro, clinicamente significativo dell&#39;anticorpo contro il sistema di gruppo sanguigno di alta frequenza eritrociti antigene Kp(b) di Kell. Qui riportiamo un caso di malattia emolitica del neonato (HDN) a causa di anti-Kp(b), che si manifesta come grave anemia all&#39;et&agrave; di 1 mese.

il tarda ad esordio neonatale anemia materna anti-Kp(b) indotta da malattia emolitica del neonato.

The high-cure rates of 90% in retinoblastoma are not replicated in developing countries due to late presentation and poor compliance to treatment. The present study takes a closer look at causes of abandonment of therapy and effectiveness of counselling in reducing abandonment.

Causes, outcome and prevention of abandonment in retinoblastoma in India.

Le taux de haute-gu&eacute;rison de 90 % dans le r&eacute;tinoblastome n&#39;est pas r&eacute;pliqu&eacute; dans les pays en d&eacute;veloppement en raison de la pr&eacute;sentation en retard et le manque d&#39;observance au traitement. La pr&eacute;sente &eacute;tude examine de plus pr&egrave;s aux causes de l&#39;abandon du traitement et l&#39;efficacit&eacute; des services de counseling pour r&eacute;duire l&#39;abandon.

Les causes, les r&eacute;sultats et pr&eacute;vention de l&#39;abandon dans le r&eacute;tinoblastome en Inde.

Le tariffe di alta cura del 90% di retinoblastoma non vengono replicate nei paesi in via di sviluppo a causa della tardiva presentazione e scarsa compliance al trattamento. Il presente studio prende uno sguardo ravvicinato alle cause di abbandono della terapia e l&#39;efficacia della consulenza nel ridurre l&#39;abbandono.

Cause, esito e la prevenzione dell&#39;abbandono nel retinoblastoma in India.

The role of oral ribavirin in treatment and containment of a measles outbreak in 15 children in an oncology unit is presented. Measles was diagnosed on clinical features and history of contact. Measles specific IgM ELISA and RNA were positive in 7 of 15 and 2 of 7 tested children, respectively. Duration of illness was longer in unimmunized as compared to immunized children (Pâ€‰=â€‰0.02). Complications were higher in hematological malignancies (Pâ€‰=â€‰0.025). Delay in starting ribavirin was associated with fatal complications (2 of 2 vs. 0 of 13, Pâ€‰=â€‰0.009). Ribavirin prevented measles in all (21 of 21) patients exposed to the cases. Pediatr Blood Cancer 2013;9999:XX-XX. Â© 2013 Wiley Periodicals, Inc.

Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak.

Le r&ocirc;le de la ribavirine par voie orale dans le traitement et le confinement d&#39;une flamb&eacute;e de rougeole dans 15 enfants dans une unit&eacute; d&#39;oncologie sont pr&eacute;sent&eacute;s. La rougeole a &eacute;t&eacute; diagnostiqu&eacute;e sur des signes cliniques et l&#39;histoire de contact. La rougeole sp&eacute;cifiques IgM ELISA et l&#39;ARN ont &eacute;t&eacute; positif dans 7 des 15 et 2 des 7 enfants test&eacute;s, respectivement. Dur&eacute;e de la maladie &eacute;tait plus longue dans non immunis&eacute;s par rapport aux enfants immunis&eacute;s (P = 0,02). Les complications sont plus &eacute;lev&eacute;es dans les h&eacute;mopathies malignes (P = 0,025). Retard dans le d&eacute;marrage de la ribavirine a &eacute;t&eacute; associ&eacute;e &agrave; des complications mortelles (2 de 2 vs 0 sur 13, P = 0,009). Ribavirine a emp&ecirc;ch&eacute; la rougeole &agrave; tous (21 de 21) patients expos&eacute;s aux cas. Pediatr Blood Cancer 2013 ; 9999:XX-XX. &copy; 2013 Wiley p&eacute;riodiques, Inc.

&Eacute;closion de rougeole dans une unit&eacute; d&#39;oncologie p&eacute;diatrique et le r&ocirc;le de la ribavirine en pr&eacute;vention des complications et d&#39;endiguement de l&#39;&eacute;pid&eacute;mie.

Viene presentati il ruolo della ribavirina orale nel trattamento e contenimento di un focolaio di morbillo in 15 bambini in un&#39;unit&agrave; di oncologia. Morbillo &egrave; stato diagnosticato su caratteristiche cliniche e la storia del contatto. Morbillo IgM ELISA specifico e RNA sono stati positivi in 7 dei 15 e 2 di 7 bambini testati, rispettivamente. Durata della malattia &egrave; stato pi&ugrave; a lungo in unimmunized rispetto ai bambini immunizzati (P = 0,02). Le complicanze erano superiori in neoplasie ematologiche (P = 0.025). Ritardo in partenza ribavirina &egrave; stata associata a complicanze fatali (2 of 2 vs 0 13, P = 0.009). Ribavirina ha impedito il morbillo in tutti (21 di 21) i pazienti esposti a casi. Cancro di anima di Pediatr 2013; 9999:XX-XX. &copy; 2013 Wiley periodici, Inc.

Epidemia di morbillo in un&#39;unit&agrave; di oncologia pediatrica e il ruolo della ribavirina nella prevenzione delle complicanze e contenimento dell&#39;epidemia.

Article	Year
Lipid peroxidation and antioxidant status in the blood of children with aplastic anemia. Clinica chimica acta; international journal of clinical chemistry\| PubMed ID: 16935276	2006
Blood lead levels in children of Lucknow, India. Environmental toxicology\| PubMed ID: 19161238	2010
A pilot study on parvovirus B19 infection in paediatric haematological malignancies. The Indian journal of medical research\| PubMed ID: 21537094	2011
Oral & maxillofacial manifestations in pediatric esthesioneuroblastoma-report of a case and review of literature. Pediatric dentistry\| PubMed ID: 21703080	2011
Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixture. Inflammatory bowel diseases\| PubMed ID: 22447396	2012
Dental management of a pediatric patient with Burkitt lymphoma: a case report. Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry\| PubMed ID: 22591435	2012
Late onset neonatal anaemia due to maternal anti-Kp(b) induced haemolytic disease of the newborn. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis\| PubMed ID: 23089052	2012
Causes, outcome and prevention of abandonment in retinoblastoma in India. Pediatric blood & cancer\| PubMed ID: 23303533	2013
Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak. Pediatric blood & cancer\| PubMed ID: 23629813	2013

Archana Kumar

Biography

JoVE Journal Publications

Other Publications